Acute Superior Vena Cava Syndrome in the Setting of an Intravascular Device by Kinney, Rachel, DO et al.
Lehigh Valley Health Network
LVHN Scholarly Works
Department of Medicine
Acute Superior Vena Cava Syndrome in the Setting
of an Intravascular Device
Rachel Kinney DO
Lehigh Valley Health Network, rachel.kinney@lvhn.org
Matthew Miles DO
Lehigh Valley Health Network, Matthew.Miles@lvhn.org
Shannon Davis DO
Lehigh Valley Health Network, Shannon.Davis@lvhn.org
Jennifer Rovella DO
Lehigh Valley Health Network, jennifer_c.rovella@lvhn.org
Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine
Part of the Medical Sciences Commons, and the Pulmonology Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Kinney, R., Miles, M., Davis, S., Rovella, J. (2015, April 30). Acute Superior Vena Cava Syndrome in the Setting of an Intravascular Device.
Poster presented at: POMA Convention, Valley Forge, PA.
© 2015 Lehigh Valley Health Network
References:
1	 	Wilson	LD,	Detterbeck	FC,	Yahalom	J.	Clinical	practice.	Superior	vena	cava	syndrome	with	malignant	causes.	N Engl J Med	2007;	356:1862.	
2	 	Rice	TW,	Rodriquez	RM,	Light	RW.	The	superior	vena	cava	syndrome:	clinical	characteristics	and	evolving	etiology.	Medicine	(Baltimore)	2006;85:37-42.	
3	 	Kalra	M,	Gloviczki	P,	Andrews	JC,	et	al.	Open	surgical	and	endovascular	treatment	of	superior	vena	cava	syndrome	caused	by	nonmalignant	disease.	J Vasc Surg.	2003	Aug;38(2):215-223.		
4	 	Kee	ST,	Kinoshita	L,	Razavi	MK,	Nyman	UR,	Semba	CP,	Dake	MD.	Superior	vena	cava	syndrome:	treatment	with	catheter-directed	thrombolysis	and	endovascular	stent	placement.	Radiology.	
1998	Jan;206(1):187-193.		
5	 	Crowe	MT,	Davies	CH,	Gaines	PA.	Percutaneous	management	of	superior	vena	cava	occlusions.	Cardiovasc Intervent Radiol.	1995	Nov-Dec;18(6):367-372.					
6	 Warner	P,	Uberoi	R.	Superior	vena	cava	stenting	in	the	21st	century.	Postgrad Med J	2013;	89:224.
7	 	Smayra	T,	Otal	P,	Chabbert	V,	et	al.	Long-term	results	of	endovascular	stent	placement	in	the	superior	vena	caval	venous	system.	Cardiovasc Intervent Radiol	2001;24:388-394.
 
Superior Vena Cava (SVC) syndrome is often associated with a malignancy that causes obstruction of the SVC resulting in 
decreased venous drainage from the head and neck. It most commonly presents with neck, facial, and upper extremity 
swelling, dyspnea or cough.  The clinical effects of SVC syndrome range from mild aesthetic disturbances to life-threatening 
situations and hemodynamic instability. Increased venous pressure and edema may compromise the larynx and pharynx, 
leading to symptoms of stridor and dysphagia. Furthermore, confusion and coma may result from increased cerebral edema. 
Therefore prompt recognition and treatment is necessary.
 
A 34-year-old Caucasian female presented with dyspnea and a two-month history of facial swelling and discoloration, 
exacerbated when bending over. Past medical history was significant for methylenetetrahydrofolate reductase deficiency, history 
of provoked pulmonary embolism, and T2N0 left breast infiltrating ductal carcinoma. The patient was receiving chemotherapy 
through a right jugular venous catheter, inserted 4 months ago. On physical exam, the patient had facial cyanosis and edema 
extending to the anterior chest, tachycardia and decreased breath sounds. A chest wall medi-port was in place, terminating 
in the SVC. The remainder of her exam was within normal limits.  A CT scan of the neck, chest abdomen and pelvis revealed 
acute thrombosis within the SVC and extensive collaterals throughout the pericardium, esophagus, and back musculature. 
Subsegmental bilateral pulmonary emboli were noted within the lower lobes. A superior venocavogram revealed totally occlusive 
thrombus in the mid to lower portion of the SVC and a small non-occlusive thrombus in the upper portion of the SVC. The right 
jugular venous port was present with the tip in the midportion of the SVC with the SVC occluded below the level of the catheter 
tip. The patient was subsequently started on a heparin drip and underwent catheter directed tPA. After 16.5 hours of tPA repeat 
superior venacavogram showed that the previous 
thrombus in SVC had only a small decrease in size with 
the development of several tiny channels of flow around 
the thrombus to the right atrium.  The residual thrombus 
was macerated first with a 4 mm diameter angioplasty 
balloon followed by a 6 mm diameter angioplasty balloon 
to create multiple small flow channels.  tPA thrombolysis 
was continued for an additional 45.5 hours for a total 
of 62 hours. Repeat superior venacavogram showed 
excellent flow in the SVC with minimal fibrin sheath 
arising from the catheter tip.  The patient had no bleeding 
complications from tPA therapy and the patient’s facial 
cyanosis and edema significantly improved.  The venous 
catheter was removed 3 days later and patient was 
discharged home on enoxaparin. 
•  SVC syndrome is most commonly caused by obstruction of the SVC by invasion or extrinsic compression by malignancies such as non-
small cell lung cancer, lymphoma, metastases or thymomas. 
•  A smaller portion of patients with SVC syndrome have non-malignant causes such as thrombosis, post-radiation fibrosis or an infectious 
etiology. 
•  Due to the increasing use of intravascular devices, such as central venous catheters and pacemaker/defibrillator leads, a larger portion 
of SVC syndromes now occur from benign causes which may account for up to 40% of SVC cases.2
•  Treatment of SVC syndrome is accomplished by removing or attempting to decrease the size of the mass or thrombus causing the 
obstruction and is guided by the etiology and severity of symptoms on presentation.
•  Options for treatment for SVC syndrome include: thrombolysis, endovascular stenting, balloon angioplasty, venous grafting or 
mechanical thrombectomy.
•  Stent placement is a commonly used treatment and has been shown to be successful in both benign and malignant causes of SVC 
syndrome.3
•  In thrombus induced SVC syndrome, thrombolysis prior to stent placement  has been shown to be successful,4,5  however, it has also 
shown to increase morbidity therefore making this combined strategy less desirable.6 
•  Stent placement also has its own risks such as: infection, pulmonary emboli, stent migration, hematoma formation, or SVC rupture.7
•  In this case, due to the large extent of clot burden, the patient had a combination of catheter directed tPA and balloon angioplasty.
•  After 62 hrs of tPA, infusion catheter check relieved excellent flow through the SVC therefore not requiring stent placement. 
•  Patient’s symptoms significantly and quickly improved with the above treatment.
Image 1. Ct scan showing occluded SVC with collateral 
vessels.
Image 2. Venogram showing occlusion of 




•  Due to the increasing use of intravascular devices, a larger portion of SVC syndromes now occur from benign causes.
•  Percutaneous angioplasty can be used as an adjunct to tPA therapy to accelerate clot dissolution and successfully treat thrombus 
induced SVC syndrome, without the need for stent placement.
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